LOW DOSE SPIRONOLACTONE MONO-THERAPY IN THE MANAGEMENT OF STAGE ONE ESSENTIAL HYPERTENSION: A PILOT RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

sadeghi Amir Abbas; AMIRMOEZI FATEMEH; ATTAR ARMIN; AGHASADEGHI KAMRAN

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Seminar Paper

Paper Information

Seminar: INTERNATIONAL PREVENTIVE CARDIOLOGY CONGRESS
Year:2016 | Issue:5

Download Full-Text

View:

126

Download:

Information Seminar Paper

Title

LOW DOSE SPIRONOLACTONE MONO-THERAPY IN THE MANAGEMENT OF STAGE ONE ESSENTIAL HYPERTENSION: A PILOT RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

Author(s)

sadeghi Amir Abbas | AMIRMOEZI FATEMEH | ATTAR ARMIN | AGHASADEGHI KAMRAN

Keywords

SPIRONOLACTONE

MONO-THERAPY

ESSENTIAL HYPERTENSION

BLOOD PRESSURE

SERUM POTASSIUM

Abstract

BACKGROUND: HIGH BLOOD PRESSURE IS A COMMON CHRONIC DISEASE NEED LONG LIFE DRUG CONSUMPTION TO CONTROL. ACCORDING TO THE BRITISH HYPERTENSION SOCIETY GUIDELINE, SPIRONOLACTONE, AS AN ALDOSTERONE ANTAGONIST AND A POTASSIUM SPARING DIURETIC, COULD BE USED AS THE FOURTH LINE THERAPY IN PATIENTS WITH RESISTANT HYPERTENSION. HOWEVER, THERE IS NO STUDY TO DETERMINE THE EFFECTS OF SPIRONOLACTONE AS A FIRST LINE THERAPY IN TREATMENT OF ESSENTIAL HYPERTENSION....

Cites

No record.

References

No record.

Cite

APA: Copy

sadeghi, Amir Abbas, AMIRMOEZI, FATEMEH, ATTAR, ARMIN, & AGHASADEGHI, KAMRAN. (2016). LOW DOSE SPIRONOLACTONE MONO-THERAPY IN THE MANAGEMENT OF STAGE ONE ESSENTIAL HYPERTENSION: A PILOT RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL. INTERNATIONAL PREVENTIVE CARDIOLOGY CONGRESS. SID. https://sid.ir/paper/938303/en

Vancouver: Copy

sadeghi Amir Abbas, AMIRMOEZI FATEMEH, ATTAR ARMIN, AGHASADEGHI KAMRAN. LOW DOSE SPIRONOLACTONE MONO-THERAPY IN THE MANAGEMENT OF STAGE ONE ESSENTIAL HYPERTENSION: A PILOT RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL. 2016. Available from: https://sid.ir/paper/938303/en

IEEE: Copy

Amir Abbas sadeghi, FATEMEH AMIRMOEZI, ARMIN ATTAR, and KAMRAN AGHASADEGHI, “LOW DOSE SPIRONOLACTONE MONO-THERAPY IN THE MANAGEMENT OF STAGE ONE ESSENTIAL HYPERTENSION: A PILOT RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL,” presented at the INTERNATIONAL PREVENTIVE CARDIOLOGY CONGRESS. 2016, [Online]. Available: https://sid.ir/paper/938303/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops